These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 16393975

  • 1. IFN-dependent down-regulation of the NKG2D ligand H60 on tumors.
    Bui JD, Carayannopoulos LN, Lanier LL, Yokoyama WM, Schreiber RD.
    J Immunol; 2006 Jan 15; 176(2):905-13. PubMed ID: 16393975
    [Abstract] [Full Text] [Related]

  • 2. NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors.
    Regunathan J, Chen Y, Wang D, Malarkannan S.
    Blood; 2005 Jan 01; 105(1):233-40. PubMed ID: 15328154
    [Abstract] [Full Text] [Related]

  • 3. Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60.
    O'Callaghan CA, Cerwenka A, Willcox BE, Lanier LL, Bjorkman PJ.
    Immunity; 2001 Aug 01; 15(2):201-11. PubMed ID: 11520456
    [Abstract] [Full Text] [Related]

  • 4. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
    Diefenbach A, Hsia JK, Hsiung MY, Raulet DH.
    Eur J Immunol; 2003 Feb 01; 33(2):381-91. PubMed ID: 12645935
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer.
    Dasgupta S, Bhattacharya-Chatterjee M, O'Malley BW, Chatterjee SK.
    J Immunol; 2005 Oct 15; 175(8):5541-50. PubMed ID: 16210663
    [Abstract] [Full Text] [Related]

  • 9. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
    Schwinn N, Vokhminova D, Sucker A, Textor S, Striegel S, Moll I, Nausch N, Tuettenberg J, Steinle A, Cerwenka A, Schadendorf D, Paschen A.
    Int J Cancer; 2009 Apr 01; 124(7):1594-604. PubMed ID: 19089914
    [Abstract] [Full Text] [Related]

  • 10. Cutting edge: the minor histocompatibility antigen H60 peptide interacts with both H-2Kb and NKG2D.
    Cerwenka A, O'Callaghan CA, Hamerman JA, Yadav R, Ajayi W, Roopenian DC, Joyce S, Lanier LL.
    J Immunol; 2002 Apr 01; 168(7):3131-4. PubMed ID: 11907062
    [Abstract] [Full Text] [Related]

  • 11. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
    Girart MV, Fuertes MB, Domaica CI, Rossi LE, Zwirner NW.
    J Immunol; 2007 Sep 15; 179(6):3472-9. PubMed ID: 17804388
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. NKG2D-independent suppression of T cell proliferation by H60 and MICA.
    Kriegeskorte AK, Gebhardt FE, Porcellini S, Schiemann M, Stemberger C, Franz TJ, Huster KM, Carayannopoulos LN, Yokoyama WM, Colonna M, Siccardi AG, Bauer S, Busch DH.
    Proc Natl Acad Sci U S A; 2005 Aug 16; 102(33):11805-10. PubMed ID: 16091471
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
    Doubrovina ES, Doubrovin MM, Vider E, Sisson RB, O'Reilly RJ, Dupont B, Vyas YM.
    J Immunol; 2003 Dec 15; 171(12):6891-9. PubMed ID: 14662896
    [Abstract] [Full Text] [Related]

  • 17. Opposing effects of interferon-alpha and interferon-gamma on the expression of major histocompatibility complex class I chain-related A in tumors.
    Zhang C, Niu J, Zhang J, Wang Y, Zhou Z, Zhang J, Tian Z.
    Cancer Sci; 2008 Jun 15; 99(6):1279-86. PubMed ID: 18422748
    [Abstract] [Full Text] [Related]

  • 18. [Effects of NKG2D and its ligands RAE-1 and H60 on graft-versus-tumor response].
    Li XF, Chen Q, Ye YB, Fan LF, Chen MS, Li JY, Chen HQ, Chen SP, Zhou ZF.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb 15; 15(1):160-4. PubMed ID: 17490545
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
    Zhang C, Zhang J, Niu J, Zhou Z, Zhang J, Tian Z.
    Hum Immunol; 2008 Aug 15; 69(8):490-500. PubMed ID: 18619507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.